In recognition of World Environment Month, Genmab colleagues in Japan were proud to continue our longstanding partnership with Maggie’s Tokyo by helping beautify their garden for visitors to enjoy. Maggie’s Tokyo is a welcoming place where people living with cancer, as well as their families and friends, can connect with healthcare professionals and receive support. Through this volunteer activity, we aimed to help maintain a peaceful space for patients and their loved ones. This meaningful project reflects Genmab’s commitment to supporting environmental initiatives and patient communities and creating a positive impact in the communities where we live and work.
Welcome to Genmab’s June Edition of Knock-Your-Socks-Off-News, a monthly newsletter covering our current happenings across the globe. Follow along with us on our journey for more updates as we advance innovation and continue to work towards our goal of transforming the lives of patients through antibody medicines.
We’re pleased to announce that Margarida Duarte has joined Genmab as General Manager for Europe and Emerging Markets. This appointment marks an important step as we continue to strengthen our presence across the region and work to bring innovative antibody medicines to more patients. Welcome, Margarida, to Genmab! Read more here: http://gmab.ly/AXfe50YzjrE.
Learn how Genmab began with a bold idea to harness the power of antibodies to fight cancer and other serious diseases and how that vision is now making an impact for patients. From challenging the status quo to leveraging data-driven insights, this video highlights how we are advancing antibody medicines with patients at the center of every step. At Genmab, we don’t just focus on antibodies — we focus on the people behind every breakthrough.
Three Genmab colleagues were recently elected to our Board of Directors for a three-year term, continuing our long-standing tradition of employee representation. This ensures our team’s voice is part of decision-making and strengthens our culture of collaboration and innovation. Congratulations Martin Schultz, Mijke Zachariasse and Mike Kavanagh on being elected to our board of directors by Genmab colleagues!
Growing Together for a Greener Future! Recently, our amazing colleagues and Trees for All came together to plant trees in the stunning forests of Het Groene Woud in Brabant. This initiative reflects our shared commitment to sustainability and making a meaningful impact on the communities where we live and work. Together, we’re taking small but powerful steps toward a cleaner, greener world for generations to come. Thank you to everyone who made this day a success!
ICYMI: We recently published our 2024 Annual Report. Executive Vice President and Chief Financial Officer Anthony Pagano shares how our strategic investments and focus on late-stage programs are driving our evolution into a biotech innovation powerhouse. Read the report: http://gmab.ly/uvbl50UYQ4c
Genmab Welcomes Future Scientists to Explore the World of Biotechnology! We are proud to have hosted 80 high school students from Amadeus Lyceum at our R&D Center in Utrecht, where students had a unique glimpse into the innovative work we do at Genmab. Students spent the day participating in workshops and touring our facilities. We are excited to inspire the next generation of scientists by sharing our passion for innovation, driven by our purpose to improve the lives of patients through innovative antibody therapeutics.
In honor of Genmab's 25th anniversary and its dedication to supporting the next generation of leaders in science, the Genmab Jan van de Winkel Scholarship Fund was established in collaboration with Utrecht University this year. The first recipient of this scholarship has been awarded to Miguel Vieira Martins, a pediatric oncology PhD student in the Máxima Butterfly program at the Prinses Máxima Centrum voor kinderoncologie. Miguel represents the rise of the next generation of scientists prepared to make an impact on patients. Miguel shared: “The Jan van de Winkel Scholarship will support my clinical research secondment in the United Kingdom, helping me deepen my understanding, progress my work, and share results in the months ahead. I was very impressed by the friendly environment and facilities at Genmab, where a culture of critical thinking, transparency, and curiosity fosters productivity and growth.” It was wonderful to welcome Miguel to our site in Utrecht and share our drive to advance research with a goal of positively impacting the lives of patients. Read more here: http://gmab.ly/8EUa50Uon3Z.
#InvestorUpdate: We’ve published our Interim Report for the first nine months of 2024. Hear from Anthony Pagano, Executive Vice President & Chief Financial Officer on our progress toward our goal to impact patients’ lives with antibody medicines.
